Literature DB >> 10448066

Serum induction of the collagen X promoter requires the Raf/MEK/ERK and p38 pathways.

F Beier1, P LuValle.   

Abstract

The collagen X gene is expressed exclusively by differentiated, hypertrophic chondrocytes. The mechanisms controlling collagen X expression remain largely unknown. Here we show that collagen X promoter activity can be induced by serum stimulation of chondrogenic MCT cells. The serum response is conferred by a 462 nucleotide promoter fragment. Both the c-Raf/MEK/ERK and p38 MAP kinase pathways are required for this effect, whereas phosphatidylinositol-3-kinase and protein kinase A repress promoter activation. These data are the first to demonstrate serum inducibility of the collagen X promoter and to identify signal transduction pathways involved. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448066     DOI: 10.1006/bbrc.1999.1178

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation.

Authors:  Lee-Anne Stanton; Shalev Sabari; Arthur V Sampaio; T Michael Underhill; Frank Beier
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

Review 2.  A review of crosstalk between MAPK and Wnt signals and its impact on cartilage regeneration.

Authors:  Ying Zhang; Tyler Pizzute; Ming Pei
Journal:  Cell Tissue Res       Date:  2014-10-14       Impact factor: 5.249

3.  Chicken collagen X regulatory sequences restrict transgene expression to hypertrophic cartilage in mice.

Authors:  Michelle R Campbell; Catherine J Gress; Elizabeth H Appleman; Olena Jacenko
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

4.  Differential effects of ERK and p38 signaling in BMP-2 stimulated hypertrophy of cultured chick sternal chondrocytes.

Authors:  Gwendolen C Reilly; Eleanor B Golden; Giovi Grasso-Knight; Phoebe S Leboy
Journal:  Cell Commun Signal       Date:  2005-02-03       Impact factor: 5.712

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.